Infectious Disease Diagnostics Market Report: Unlocking Growth Potential and Addressing Challenges
United States of America – July 22, 2025 – The Insight Partners proudly presents its latest market intelligence publication titled, “Infectious Disease Diagnostics Market: An In-depth Analysis of Trends, Innovation, and Forecast (2023–2030).” This report delivers a holistic view of the infectious disease diagnostics industry, spotlighting growth factors, evolving technologies, and strategic opportunities through 2030.
Overview of the Infectious Disease Diagnostics Market
The infectious disease diagnostics market is undergoing a major transformation driven by rising global health threats, the spread of zoonotic diseases, and increasing demand for rapid, accurate, and decentralized testing methods. With governments, healthcare providers, and biotech companies investing in next-gen technologies, the market is poised for consistent expansion over the forecast period.
Key Findings and Insights
Market Size:
Valued at US$ 38.37 Billion in 2022, the market is projected to reach US$ 59.95 Billion by 2030, growing at a CAGR of 5.7% between 2023 and 2030.Primary Drivers:
– Rising prevalence of infectious diseases (e.g., COVID-19, HIV, hepatitis, influenza)
– Increased demand for point-of-care testing (POCT)
– Advancements in molecular diagnostics and biosensors
– Rising focus on early diagnosis and personalized medicine
Market Segmentation
By Product
Kits & Reagents
Instruments
Software & Services
By Technology
Biosensor-Based Diagnostics
Immunodiagnostics
Molecular-Based Diagnostic Techniques
Clinical Biology
By Application Type
Laboratory Testing
Point-of-Care Testing
By Testing Type
Human Testing
Veterinary Testing
This detailed segmentation reflects the diversity in diagnostic approaches and highlights trends in rapid detection, decentralized testing, and cross-species disease monitoring.
Spotting Emerging Trends
Technological Advancements
Next-gen diagnostics leverage CRISPR, AI-powered platforms, real-time PCR, and nanotechnology for improved speed, accuracy, and portability in disease detection.
Changing Testing Dynamics
Consumer demand is shifting toward faster, self-administered, and connected diagnostic tools that reduce hospital visits and improve outcomes.
Regulatory Landscape
Supportive government policies, emergency use authorizations (EUAs), and increased funding for diagnostic research are expediting innovation and market access.
Growth Opportunities
Expansion of POCT and home diagnostics for emerging and re-emerging diseases
Growing adoption of biosensors in mobile health (mHealth) applications
Veterinary diagnostics to monitor zoonotic disease transmission
AI- and machine learning-enabled test result interpretation
Conclusion
The Infectious Disease Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2031 report provides much-needed insight for a company willing to set up its operations in the Infectious Disease Diagnostics Market. Since an in-depth analysis of competitive dynamics, the environment, and probable growth path are given in the report, a stakeholder can move ahead with fact-based decision-making in favor of market achievements and enhancement of business opportunities.
About The Insight Partners
The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.
To know more and get access to Sample reports.
https://www.theinsightpartners.com/sample/TIPHE100001430
